206 related articles for article (PubMed ID: 32105561)
21. Melanoma of the external ear: A population-based study.
Deep NL; Glasgow AE; Habermann EB; Kasperbauer JL; Carlson ML
Am J Otolaryngol; 2017; 38(3):309-315. PubMed ID: 28258767
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the eighth American Joint Committee on Cancer staging system for malignant melanoma of the skin.
Abdel-Rahman O
Future Oncol; 2018 Feb; 14(5):471-481. PubMed ID: 29322826
[TBL] [Abstract][Full Text] [Related]
23. Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
Haydu LE; Lo SN; McQuade JL; Amaria RN; Wargo J; Ross MI; Cormier JN; Lucci A; Lee JE; Ferguson SD; Saw RPM; Spillane AJ; Shannon KF; Stretch JR; Hwu P; Patel SP; Diab A; Wong MKK; Glitza Oliva IC; Tawbi H; Carlino MS; Menzies AM; Long GV; Lazar AJ; Tetzlaff MT; Scolyer RA; Gershenwald JE; Thompson JF; Davies MA
J Clin Oncol; 2020 May; 38(13):1429-1441. PubMed ID: 31990608
[TBL] [Abstract][Full Text] [Related]
24. Tumor mitotic rate is an independent predictor of survival for nonmetastatic melanoma.
Evans JL; Vidri RJ; MacGillivray DC; Fitzgerald TL
Surgery; 2018 Sep; 164(3):589-593. PubMed ID: 29929753
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.
Balch CM; Soong SJ; Gershenwald JE; Thompson JF; Reintgen DS; Cascinelli N; Urist M; McMasters KM; Ross MI; Kirkwood JM; Atkins MB; Thompson JA; Coit DG; Byrd D; Desmond R; Zhang Y; Liu PY; Lyman GH; Morabito A
J Clin Oncol; 2001 Aug; 19(16):3622-34. PubMed ID: 11504744
[TBL] [Abstract][Full Text] [Related]
26. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
Satzger I; Leiter U; Gräger N; Keim U; Garbe C; Gutzmer R
Eur J Cancer; 2019 Dec; 123():83-91. PubMed ID: 31677550
[TBL] [Abstract][Full Text] [Related]
27. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
[TBL] [Abstract][Full Text] [Related]
28. External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?
Madu MF; Franke V; Van de Wiel BA; Klop WMC; Jóźwiak K; van Houdt WJ; Wouters MWJM; van Akkooi ACJ
Melanoma Res; 2020 Apr; 30(2):185-192. PubMed ID: 31651715
[TBL] [Abstract][Full Text] [Related]
29. Survival of acral lentiginous melanoma in the National Cancer Institute of Colombia.
Duarte CA; Flórez JP; López HG; Meneses MX; de Vries E
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):438-442. PubMed ID: 27518480
[TBL] [Abstract][Full Text] [Related]
30. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
Abdel-Rahman O
Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
[TBL] [Abstract][Full Text] [Related]
31. Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage.
Teterycz P; Ługowska I; Koseła-Paterczyk H; Rutkowski P
World J Surg Oncol; 2019 Jul; 17(1):129. PubMed ID: 31345228
[TBL] [Abstract][Full Text] [Related]
32. Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes.
Steadman JA; Glasgow AE; Neequaye NN; Habermann EB; Hieken TJ
J Surg Oncol; 2024 May; 129(6):1041-1050. PubMed ID: 38436625
[TBL] [Abstract][Full Text] [Related]
33. A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden.
Isaksson K; Katsarelias D; Mikiver R; Carneiro A; Ny L; Olofsson Bagge R
Ann Surg Oncol; 2019 Sep; 26(9):2839-2845. PubMed ID: 31111349
[TBL] [Abstract][Full Text] [Related]
34. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
[TBL] [Abstract][Full Text] [Related]
35. Melanoma survival in the United States, 1992 to 2005.
Pollack LA; Li J; Berkowitz Z; Weir HK; Wu XC; Ajani UA; Ekwueme DU; Li C; Pollack BP
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S78-86. PubMed ID: 22018071
[TBL] [Abstract][Full Text] [Related]
36. Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis.
Haydu LE; Scolyer RA; Lo S; Quinn MJ; Saw RPM; Shannon KF; Spillane AJ; Stretch JR; McCarthy WH; Thompson JF
J Clin Oncol; 2017 May; 35(15):1721-1729. PubMed ID: 28375785
[TBL] [Abstract][Full Text] [Related]
37. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
[TBL] [Abstract][Full Text] [Related]
38. Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging.
Wisco OJ; Marson JW; Litchman GH; Brownstone N; Covington KR; Martin BJ; Quick AP; Siegel JJ; Caruso HG; Cook RW; Winkelmann RR; Rigel DS
Melanoma Res; 2022 Apr; 32(2):98-102. PubMed ID: 35254332
[TBL] [Abstract][Full Text] [Related]
39. The impact of prognostic factors and comorbidities on survival in older adults with stage I - III cutaneous melanoma in Southwest Finland: A register study.
Mattila KE; Vihinen H; Heervä E; Nuotio MS; Vihinen P
J Geriatr Oncol; 2024 Mar; 15(2):101701. PubMed ID: 38219332
[TBL] [Abstract][Full Text] [Related]
40. Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning.
Yang CQ; Wang H; Liu Z; Hueman MT; Bhaskaran A; Henson DE; Sheng L; Chen D
PLoS One; 2021; 16(9):e0257949. PubMed ID: 34591891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
